Alternating Hemiplegia and Cardiac Dysrhythmia

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Alternating hemiplegia is a rare and severe neurological disorder characterized by recurrent episodes of unilateral or bilateral weakness.
• The genetic underpinnings of alternating hemiplegia are not fully understood, necessitating further investigation into causative genes.

Purpose of the Study:

• To investigate the genetic mutations associated with alternating hemiplegia.
• To identify the role of the ATP1A3 gene in the pathogenesis of this condition.

Main Methods:

• Analysis of electrocardiogram (ECG) recordings from 52 patients diagnosed with alternating hemiplegia across 9 countries.
• Comprehensive genetic sequencing (whole-exome, whole-genome, Sanger sequencing) was performed on all participating patients.
• Focus on identifying mutations within the ATP1A3 gene.

Main Results:

• A significant proportion of patients (47 out of 52) were found to have a confirmed missense mutation in the ATP1A3 gene.
• The study involved international collaboration, including centers in the UK, Europe, US, Australia, and Canada.

Conclusions:

• Missense mutations in the ATP1A3 gene are strongly associated with alternating hemiplegia.
• These findings highlight ATP1A3 as a key gene involved in the pathophysiology of alternating hemiplegia, paving the way for future research and potential therapeutic targets.